FK 506 treatment following syngeneic bone marrow transplantation does not inhibit clonal deletion of V beta 5+ or V beta 11+ T cells

Transplant Proc. 1992 Dec;24(6):3031.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bone Marrow Transplantation / immunology*
  • CD4-CD8 Ratio
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology
  • Graft Rejection / immunology*
  • Graft Survival / drug effects*
  • Graft Survival / immunology
  • Leukocyte Count / drug effects
  • Lymphocyte Activation / drug effects*
  • Lymphocyte Activation / immunology
  • Male
  • Mice
  • Mice, Inbred Strains
  • Receptors, Antigen, T-Cell, alpha-beta / drug effects*
  • Receptors, Antigen, T-Cell, alpha-beta / immunology
  • Tacrolimus / pharmacology*

Substances

  • Receptors, Antigen, T-Cell, alpha-beta
  • Tacrolimus